文献速递血液净化与透析

腹膜透析结局与实践模式研究中性别特异性结局

Sex-Specific Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-12-10

该研究基于国际PDOPPS多国数据,纳入26292例腹膜透析患者,女性占43%。调整混杂因素后,女性较男性全因死亡、转血液透析、复合终点及首次腹膜炎风险均更低,而移植风险相似;糖尿病显著减弱女性死亡和转血透风险优势。

要点

  • 女性腹膜透析患者死亡、转血透及腹膜炎风险均低于男性
  • 女性与男性肾移植风险相似(aHR 0.97,95%CI 0.87-1.08)
  • 糖尿病显著减弱女性死亡和转血透风险优势

核心结论

  • 女性腹膜透析患者较男性死亡、转血液透析、复合终点及首次腹膜炎风险更低,移植风险相似。
  • 糖尿病显著减弱女性死亡和转血透风险优势。

研究设计与样本

  • 国际PDOPPS多国前瞻性队列研究,纳入8个国家26292例腹膜透析患者,女性占43%。
  • 采用病因特异性Cox回归模型,调整地区、合并症、人口学及治疗特征。

主要发现

  • 女性较男性全因死亡率aHR 0.92(95%CI 0.86-0.99),每100患者年10.9 vs 11.3。
  • 女性转血液透析aHR 0.87(95%CI 0.83-0.92),每100患者年16.3 vs 17.9。
  • 女性复合终点aHR 0.89(95%CI 0.85-0.93),每100患者年27.2 vs 29.0。
  • 女性首次腹膜炎aHR 0.90(95%CI 0.84-0.95),每100患者年17.5 vs 18.7。
  • 女性革兰阳性腹膜炎aHR 0.73(95%CI 0.65-0.82);移植aHR 0.97(95%CI 0.87-1.08)。

临床怎么用

  • 临床管理腹膜透析患者时应考虑性别差异,女性死亡和转血透风险较低。
  • 合并糖尿病的女性患者风险优势减弱,需加强管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sex differences may influence peritoneal dialysis (PD) outcomes for individuals with kidney failure and remain poorly understood. Understanding these differences is important in optimizing dialysis care and addressing disparities in treatment outcomes. We sought to explore association of sex with PD outcomes. Data from the international PD Outcomes and Practice Patterns Study across eight countries were used to examine sex differences in outcomes, including mortality, transfer to hemodialysis, the composite of both, peritonitis risks, and kidney transplantation. Cause-specific Cox regression models were used to assess the association between sex and each clinical outcome, adjusting for region, comorbidities, demographic, and treatment characteristics. Of 26,292 included individuals on PD, 43% were female, ranging from 34% in Japan to 51% in Thailand. Women (compared with men) had lower mortality (rate per 100 patient-years [PY100], 10.9 versus 11.3; adjusted hazard ratio [aHR] of mortality, 0.92 [95% confidence intervals (CIs), 0.86 to 0.99]), transfer to hemodialysis (PY100, 16.3 versus 17.9; aHR, 0.87 [95% CI, 0.83 to 0.92]), the composite of both (PY100, 27.2 versus 29.0; aHR, 0.89 [95% CI, 0.85 to 0.93]), and time to first observed peritonitis (PY100, 17.5 versus 18.7; aHR, 0.90 [95% CI, 0.84 to 0.95]), while transplant hazards were similar (PY100, 4.0 versus 4.0; aHR, 0.97 [95% CI, 0.87 to 1.08]). In subgroup and additional analyses, sex differences in outcomes were particularly apparent in South Korea, with a median time on PD of 6.4 years for women and 4.9 years for men, with South Korea women having lower hemodialysis transfer and transplant rates. Across all countries, diabetes substantially attenuated the lower risks of death and hemodialysis transfer in women. Women had significantly lower risks of gram-positive peritonitis (aHR, 0.73 [95% CI, 0.65 to 0.82]). Compared with men, women receiving PD have lower likelihoods of mortality, hemodialysis transfer, and peritonitis. Better understanding of these findings will help inform sex-specific strategies for managing PD while enhancing personalized care approaches in this patient population.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Albakr R, Sylvertooth D, Bieber B, et al. Sex-Specific Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol. 2025. PMID: 41370095. doi:10.2215/CJN.0000000937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。